Articles

Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation

University Medical Center Hamburg-Eppendorf, Hamburg, Germany
EBMT Statistics, Leiden, the Netherlands
University of Münster, Germany
Department of Bone Marrow Transplantation, West German Cancer Center, University Hospital of Essen, Germany
EBMT Statistics, Leiden, the Netherlands
GKT School of Medicine, London, UK
EBMT Data Office, Leiden, the Netherlands
University Hospital Leipzig, Germany
Rigshospitalet, Copenhagen, Denmark
Universitätsklinikum Dresden, Germany
Chaim Sheba Medical Center, Tel-Hashomer, Israel
CHU de Lille, LIRIC, INSERM U995, Université Lille2, France
VU University Medical Center, Amsterdam, the Netherlands
Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
University Hospital Gasthuisberg, Leuven, Belgium
Universität Tübingen, Germany
Hospital Clínico, Salamanca, Spain
Deutsche Klinik für Diagnostik, Wiesbaden, Germany
Centre for Clinical Haematology, Birmingham, UK
University of Freiburg, Germany
Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
CHU Nantes, France
Hospital Santa Creu i Sant Pau, Jose Carreras Leukemia Research Institute, Barcelona, Spain
Hopital St. Louis, Paris, France
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Vol. 104 No. 5 (2019): May, 2019 https://doi.org/10.3324/haematol.2018.200808